Dr. Pravin Chaturvedi is an experienced drug developer and biotech entrepreneur.  He is the Chairman of the Scientific Advisory Board for Napo Pharmaceuticals and also serves as the CEO and Director for IndUS and Oceanyx Pharmaceuticals, both of which he also co-founded.  Previously, he has served as the President and CEO of Pivot Pharmaceuticals and Scion Pharmaceuticals.  Prior to his role at Scion, he was the Head of Lead Evaluation at Vertex and was in Product Development groups at Alkermes and Parke-Davis/Warner-Lambert (Pfizer).  Over his career, he has participated in the successful development of several new drugs for the treatment of CNS, viral and gastrointestinal disorders.

In addition to the boards of IndUS and Oceanyx, Dr. Chaturvedi is also the Chairman of the Board of Cellanyx, a first-in-class live tumor biopsy phenotypic testing enterprise.  He also serves as a board member for FuelEd Schools and Sindu Research Laboratories.  He has previously served on the boards of Pivot, Scion, Bach Pharma, PRADAN USA, Sindu Pharmaceuticals and TiE Boston.  He also serves on several advisory boards including Enlivity and MAG Optics and is as an adjunct faculty member at Georgetown Medical School.  He holds a Ph.D. from West Virginia University and received his Bachelor’s in Pharmacy from University of Bombay.